We are live on ! Find out more
OCM

Orser Capital Management Portfolio holdings

AUM $202M
1-Year Est. Return 32.65%
This Fund
S&P 500
This Quarter Est. Return
+3.56%
1 Year Est. Return
+32.65%
3 Year Est. Return
+122.2%
5 Year Est. Return
+162.36%
10 Year Est. Return
AUM
$154M
AUM Growth
-$3.99M
Cap. Flow
-$8.92M
Cap. Flow %
-5.8%
Top 10 Hldgs %
31.06%
Holding
101
New
12
Increased
23
Reduced
34
Closed
18

Top Sells

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$4.37M
2
COR
Coresite Realty Corporation
COR
+$2.56M
3
CLX icon
Clorox
CLX
+$2.39M
4
PFE icon
Pfizer
PFE
+$2.08M
5
MDT icon
Medtronic
MDT
+$2.06M

Sector Composition

Rank Sector Weight
1 Miscellaneous 31.03%
2 Technology 24.12%
3 Healthcare 11.23%
4 Consumer Staples 8.93%
5 Financials 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COR
101
DELISTED
Coresite Realty Corporation
COR
-20,395
Closed -$2.56M

Similar funds

Orser Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Orser Capital Management held 101 positions worth $154M, down 2.5% from $158M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Orser Capital Management withdrew a net $8.92M in Q1 2021, closing 18 positions and reducing 34 holdings. Its most notable exit was Edwards Lifesciences, an estimated $4.37M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 31% of assets, up from 21% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Orser Capital Management opened a new position in Vanguard S&P 500 Value ETF worth $2.25M.

  • Orser Capital Management's largest Q1 2021 buy was Vanguard S&P 500 Value ETF: 16,482 shares worth $2.25M.
  • Orser Capital Management added most to State Street Consumer Staples Select Sector SPDR ETF in Q1 2021, an estimated $1.31M increase.
  • Orser Capital Management's biggest Q1 2021 reduction was Vanguard Short-Term Treasury ETF, cutting an estimated $1.17M.
  • Orser Capital Management fully exited Edwards Lifesciences in Q1 2021, selling an estimated $4.37M.
  • Orser Capital Management's ten largest holdings make up 31% of its $154M portfolio in Q1 2021.
  • Orser Capital Management opened 12 new positions and closed 18 in Q1 2021.
  • Orser Capital Management's portfolio value fell 2.5% quarter-over-quarter to $154M.

Based on Orser Capital Management's 13F filing for Q1 2021, filed 10 May 2021.